Table 2 Follow up of the two treatment groups
From: The role of left prefrontal transcranial magnetic stimulation in episodic migraine prophylaxis
| Â | Active | Control | ||||
|---|---|---|---|---|---|---|
Baseline | Follow-up | p value | Baseline | Follow-up | p value | |
Attack frequency | 8.2(2.4) | 5.2(3.5) | 0.001 | 7.3(2.9) | 5.8(2.7) | 0.025 |
Migraine days | 9.3(1.9) | 5.5(3.2) | 0.001 | 8.9(2.1) | 6.1(2.7) | 0.001 |
Severe migraine days | 7.2(1.8) | 1.5(1.9) | 0.001 | 8.2(3.2) | 4.9(3.2) | 0.02 |
Attack duration | 15.6(17.1) | 12.8(16) | 0.001 | 5.7(16.8) | 13.1(14.1) | 0.003 |
NPRS | 8.5(1.5) | 6.4(1.8) | 0.001 | 9(1.3) | 7.7(1.9) | 0.001 |
Abortive pills | 16.5(12.1) | 10.5(9.3) | 0.001 | 14.4(10.1) | 8.4(6) | 0.009 |
HIT-6 | 72.9(5.8) | 57.5(11) | 0.001 | 69.8(8.4) | 63.6(9.6) | 0.001 |